Pipeline

SAP-002

Chronic pruritus occurs in 13% of the global population without age limitation1, leading to great impairment of quality of life.2 There is a high unmet need here as effective treatment options are still missing.

Our goal is to develop SAP-002 to add to the armamentarium for physicians treating chronic pruritus to address the unmet needs of patients with this burdensome condition.